Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score
暂无分享，去创建一个
F. Leutmezer | C. Schmied | T. Zrzavy | T. Berger | F. Deisenhammer | P. Rommer | W. Rinner | R. Ehling | G. Bsteh | K. Berek | H. Hegen | B. Kornek | P. Altmann | M. Auer | S. Wurth | Anne Zinganell | F. Di Pauli | K. Zebenholzer | Katharina Riedl | G. Zulehner | Tobias Monschein | K. Riedl